Your browser doesn't support javascript.
loading
A novel home-based method for preparing suspensions of anti-TB drugs.
Taneja, R; Nahata, M C; Scarim, J; Pande, P G; Scarim, A; Hoddinott, G; Fourie, C L; Jew, R K; Schaaf, H S; Hesseling, A C; Garcia-Prats, A J; Inabathina, K Rao.
Afiliação
  • Taneja R; Global Alliance for TB drug Development (TB Alliance), New York, NY.
  • Nahata MC; Institute of Therapeutic Innovations and Outcomes, Colleges of Pharmacy and Medicine, The Ohio State University, Columbus, OH.
  • Scarim J; JSAS Services, Tucson, AZ.
  • Pande PG; Global Alliance for TB drug Development (TB Alliance), New York, NY.
  • Scarim A; JSAS Services, Tucson, AZ.
  • Hoddinott G; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg.
  • Fourie CL; Metro TB Complex, Department of Health, Pretoria, South Africa.
  • Jew RK; Institute for Safe Medication Practices, Plymouth Meeting, PA.
  • Schaaf HS; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg.
  • Hesseling AC; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg.
  • Garcia-Prats AJ; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Inabathina KR; Global Alliance for TB drug Development (TB Alliance), New York, NY.
Int J Tuberc Lung Dis ; 27(11): 810-815, 2023 11 01.
Article em En | MEDLINE | ID: mdl-37880886
ABSTRACT

BACKGROUND:

Tablets are the most widely available dosage form for the treatment of TB; however, adult tablets fail to meet the needs of young children who cannot swallow these tablets or require dose titration. We tested a new, simple device (XTEMP-R®) and the methodology for converting tablets of TB drugs into a homogeneous suspension for home use by children and caregivers.

METHODS:

XTEMP-R is a new device used for converting tablets into liquid preparations. Four TB drugs - pretomanid, delamanid, clofazimine and bedaquiline - were dispersed in the device utilizing water and simple syrup. The reproducibility of accurately delivering aliquots from the suspension upon preparation and upon redispersion after storing for 2 days was studied.

RESULTS:

Suspensions of each of the drugs tested were easily prepared in about 10 min and were visually uniform in consistency. Dosages in 2 and 5 mL were assessed in suspension, and those in 5 mL tested upon redispersion after 2 days. The observed range for these dosages spanned from 94.6% to 101.1% of the theoretical concentration for the suspensions under examination. The cleaned device had no detectable residual drug.

CONCLUSION:

XTEMP-R can be used at home by caregivers to prepare doses of suspensions accurately for children and patients who cannot swallow tablets.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Limite: Adult / Child / Child, preschool / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Limite: Adult / Child / Child, preschool / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article